🔎 Trials Near Me

Dachaigh › Galar Ae Steatotic › Texas › San Antonio

Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an San Antonio, TX

Tha 17 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann agus timcheall air San Antonio (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

A’ fastadhÌre 3
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A’ fastadhÌre 3
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
  • 89bio Clinical Study Site, San Antonio
  • agus 2 a bharrachd
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

A’ fastadhÌre 3
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

A’ fastadhÌre 3
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

A’ fastadhÌre 2
  • American Research Corporation at The Texas Liver Institute, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

A’ fastadhÌre 2
  • American Research Corporation at The Texas Liver Institute, San Antonio
  • Pinnacle Clinical Research - San Antonio, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

A’ fastadhÌre 3
  • American Research Corporation at Texas Liver Institute, San Antonio
  • Clinical Trials of Texas, LLC dba Flourish Research, San Antonio
  • IMA Clinical Research San Antonio, San Antonio
  • agus 1 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

A’ fastadhÌre 3
  • Akero Clinical Study Site, San Antonio
  • Akero Clinical Study Site, San Antonio
  • Akero Clinical Study Site, San Antonio
  • agus 2 a bharrachd
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

A’ fastadhÌre 3
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

A’ fastadhÌre 2
  • Quality Research, Inc., San Antonio
  • Pinnacle Clinical Research - South San Antonio, San Antonio
  • Pinnacle Clinical Research, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07288138

Quantifying Hepatic Mitochondrial Fluxes in Humans

A’ fastadhÌre 4
  • Texas Diabetes Institute - University Health System, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05305287

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

A’ fastadhÌre 2
  • GSK Investigational Site, San Antonio
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

A’ fastadhÌre 3
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

A’ fastadhÌre 2
  • GSK Investigational Site, San Antonio
  • GSK Investigational Site, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06920043

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

A’ fastadhÌre 1
  • GSK Investigational Site, San Antonio
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 9 Ògmh 2026 · NCT07358546

Evaluating the Pharmacokinetics and Safety of Miricorilant

A’ fastadhÌre 1
  • Site# 433, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 26 Cèit 2026 · NCT07553663

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

A’ fastadhSgrùdadh amharc
  • Endeavor Clinical Trials, San Antonio
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Lùna 2025 · NCT07122700

Sgrùdaidhean Galar Ae Steatotic ann am bailtean eile

Sgrùdaidhean eile ann an San Antonio

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.